Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-year Prospective, Observational Study of the Journey of Patients With Plaque Psoriasis Prescribed Calcipotriol/Betamethasone Aerosol Foam or Other Topical Therapy

NCT02935582 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02935582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-year Prospective, Observational Study of the Journey of Patients With Plaque Psoriasis Prescribed Calcipotriol/Betamethasone Aerosol Foam or Other Topical Therapy
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
January 31, 2017
Completion date
December 30, 2020
Enrollment
1,214 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris